Trial Profile
Randomised, Double Blind, Controlled, Safety, Tolerability and Immunogenicity Phase II Trial of Chimerivax(TM)-Je and Japanese Encephalitis Inactivated Mouse Brain Vaccine in Children of Descending Age.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Aug 2012
Price :
$35
*
At a glance
- Drugs Japanese encephalitis vaccine (Primary) ; Measles virus vaccine live
- Indications Japanese encephalitis; Measles
- Focus Adverse reactions; Therapeutic Use
- Sponsors Sanofi
- 02 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Mar 2010 Planned end date changed from 1 Dec 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 18 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.